Sulfameter

CHEMBL1200359 Phase 4 معتمد Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

280.3 g/mol

LogP

0.4

Phase

4

Sulfameter is a very long-acting sulfonamide antibiotic with a plasma half-life of approximately 150 hours, used historically once or twice weekly for urinary tract infections and prevention of recurrent rheumatic fever. Its prolonged half-life results from slow renal excretion and extensive plasma protein binding. Like all sulfonamides, it inhibits bacterial dihydropteroate synthase. Its very long half-life increases the risk of cumulative sulfonamide toxicity.

الوزن الجزيئي

280,3100 g/mol

LogP

0,40

TPSA

116,00 Å²

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

Benign Prostatic Hyperplasia Ophthalmology Asthma Schizophrenia Generalized Anxiety Disorder Nephrology Gastroesophageal Reflux Disease Stroke Lymphoma Heart Failure Atrial Fibrillation Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1

InChI

InChI=1S/C11H12N4O3S/c1-18-9-6-13-11(14-7-9)15-19(16,17)10-4-2-8(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)

Molecular Formula

C11H12N4O3S

HBD / HBA

2 / 7

الروابط القابلة للدوران

4

الذرات الثقيلة

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

Sulfameter is a very long-acting sulfonamide antibiotic with a plasma half-life of approximately 150 hours, used historically once or twice weekly for urinary tract infections and prevention of recurrent rheumatic fever. Its prolonged half-life results from slow renal excretion and extensive plasma protein binding. Like all sulfonamides, it inhibits bacterial dihydropteroate synthase. Its very long half-life increases the risk of cumulative sulfonamide toxicity.

Yes, Sulfameter is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200359. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5326. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

هل تبحث عن معلومات ملائمة للمرضى؟

Sulfameter على PillFYI

البنية

بيانات سريعة

الصيغة الجزيئية: C11H12N4O3S

روابط خارجية

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.